Reply to: "Beta adrenergic blockade and advanced cirrhosis: Does it really improve survival in patients with acute-on-chronic liver failure?"

Affiliations

¹ Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, Austria. Electronic address: thomas.reiberger@meduniwien.ac.at.
² Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, Austria.

Comment

Thomas Reiberger et al. J Hepatol. 2017 Oct.

. 2017 Oct;67(4):880-881.

doi: 10.1016/j.jhep.2017.05.026. Epub 2017 Jun 8.

¹ Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, Austria. Electronic address: thomas.reiberger@meduniwien.ac.at.
² Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, Austria.

No abstract available

Comment on

Beta adrenergic blockade and decompensated cirrhosis.
Reiberger T, Mandorfer M. Reiberger T, et al. J Hepatol. 2017 Apr;66(4):849-859. doi: 10.1016/j.jhep.2016.11.001. Epub 2016 Nov 15. J Hepatol. 2017. PMID: 27864004 Review.
Beta adrenergic blockade and advanced cirrhosis: Does it really improve survival in patients with acute-on-chronic liver failure?
Kalambokis GN, Baltayannis G, Christodoulou D, Christou L. Kalambokis GN, et al. J Hepatol. 2017 Oct;67(4):878-880. doi: 10.1016/j.jhep.2017.02.038. Epub 2017 Jul 11. J Hepatol. 2017. PMID: 28600138 No abstract available.